Biotech was one of the top sectors in the country to receive venture capital investment, according to a new report from PricewaterhouseCoopers.
Two of 2014’s top venture capital investments were in the life sciences space: $446 million into Cambridge-based Moderna Therapeutics and $320 million into the Patrick Soon-Shiong-backed Nanthealth in SoCal (a startup that, interesting, has been recently accused by whistleblower as fraudulent).
